MENU
+Compare
ALZN
Stock ticker: NASDAQ
AS OF
Apr 24, 02:47 PM (EDT)
Price
$0.67
Change
-$0.02 (-2.90%)
Capitalization
4.55M

ALZN Alzamend Neuro Inc. Forecast, Technical & Fundamental Analysis

Alzamend Neuro Inc is an early clinical-stage biopharmaceutical company... Show more

ALZN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I.Advisor
a Summary for ALZN with price predictions
Apr 23, 2025

ALZN's RSI Indicator is staying in oversold zone for 4 days

The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an uptrend is expected.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 11 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where ALZN advanced for three days, in of 152 cases, the price rose further within the following month. The odds of a continued upward trend are .

ALZN may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on April 04, 2025. You may want to consider selling the stock, shorting the stock, or exploring put options on ALZN as a result. In of 59 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

The Moving Average Convergence Divergence Histogram (MACD) for ALZN turned negative on April 08, 2025. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 31 similar instances when the indicator turned negative. In of the 31 cases the stock turned lower in the days that followed. This puts the odds of success at .

ALZN moved below its 50-day moving average on April 07, 2025 date and that indicates a change from an upward trend to a downward trend.

The 10-day moving average for ALZN crossed bearishly below the 50-day moving average on April 10, 2025. This indicates that the trend has shifted lower and could be considered a sell signal. In of 7 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where ALZN declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

The Aroon Indicator for ALZN entered a downward trend on March 25, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.320) is normal, around the industry mean (14.056). P/E Ratio (0.000) is within average values for comparable stocks, (63.446). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (1.788). Dividend Yield (0.000) settles around the average of (0.025) among similar stocks. P/S Ratio (0.000) is also within normal values, averaging (252.992).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating slightly worse than average price growth. ALZN’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. ALZN’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.

View a ticker or compare two or three
ALZN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I. Advisor
published Earnings

ALZN is expected to report earnings to fall 73.68% to -5 cents per share on January 03

Alzamend Neuro Inc. ALZN Stock Earnings Reports
Q4'23
Est.
$-0.05
Q1'25
Beat
by $0.41
Q3'23
Missed
by $0.56
Q2'23
Missed
by $0.42
Q1'23
Missed
by $0.86
The last earnings report on March 10 showed earnings per share of -18 cents, beating the estimate of -60 cents. With 14.79K shares outstanding, the current market capitalization sits at 4.55M.
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
3480 Peachtree Road NE
Phone
+1 844 722-6333
Employees
7
Web
https://www.alzamend.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ADCT1.290.06
+4.88%
ADC Therapeutics SA
OGEN0.190.01
+3.74%
Oragenics
FULT16.440.23
+1.42%
Fulton Financial Corp
PAA17.66-0.09
-0.51%
Plains All American Pipeline LP
WOOF3.05-0.06
-1.93%
Petco Health and Wellness Company

ALZN and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, ALZN has been loosely correlated with SRPT. These tickers have moved in lockstep 49% of the time. This A.I.-generated data suggests there is some statistical probability that if ALZN jumps, then SRPT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ALZN
1D Price
Change %
ALZN100%
N/A
SRPT - ALZN
49%
Loosely correlated
+0.30%
NCNA - ALZN
47%
Loosely correlated
+14.09%
VRAX - ALZN
41%
Loosely correlated
+6.34%
SNSE - ALZN
41%
Loosely correlated
+6.90%
BPMUF - ALZN
36%
Loosely correlated
N/A
More